Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus : associations with a prothrombotic state and hypofibrinolysis
pl
dc.type
JournalArticle
pl
dc.abstract.en
Background
Type 2 diabetes mellitus (T2DM) is associated with a hypercoagulable state and increased neutrophil extracellular traps formation (NETosis). We investigated predictors of NETosis and cell death markers in circulating blood and their association with a prothrombotic state in T2DM.
Methods
In a cross-sectional study involving 113 T2DM patients aged 63.7 ± 8.2 years, we investigated citrullinated histone H3 (H3Cit), cell-free deoxyribonucleic acid (cfDNA), myeloperoxidase, neutrophil elastase, and inflammation markers, along with thrombin generation (TG), plasma clot lysis time (CLT), clot permeability (Ks) and fibrinolysis inhibitors.
Results
On multivariate logistic regression analysis adjusted for age and gender, predictors of high H3Cit (≥ 7.36 ng/mL, upper quartile) were: glycated hemoglobin (HbA1c) ≥ 7.0% and interleukin-6. Interleukin-6 was also found to be a predictor of high cfDNA (≥ 2.84 µg/mL, upper quartile) along with glucose. Citrullinated histone H3 and cfDNA correlated positively with CLT and inversely with Ks, while TG associated solely with cfDNA. These associations were not seen with myeloperoxidase and neutrophil elastase. Patients with previous myocardial infarction (n = 21, 18.6%) had higher H3Cit (+108%, p < 0.001) and cfDNA (+45%, p = 0.022). On multivariable analysis adjusted for potential confounders, H3Cit and cfDNA, along with plasminogen activator inhibitor-1 and concomitant cardiovascular disease, were predictors of CLT. Citrullinated histone H3 alone was a predictor of Ks and only cfDNA was a predictor of peak thrombin generated.
Conclusions
In T2DM, NETosis detectable in circulating blood is associated with inflammatory state and a prothrombotic state, especially hypofibrinolysis.
pl
dc.subject.en
type 2 diabetes
pl
dc.subject.en
fibrinolysis
pl
dc.subject.en
neutrophil extracellular traps
pl
dc.subject.en
fibrin clot
pl
dc.subject.en
cardiovascular disease
pl
dc.description.volume
18
pl
dc.description.points
140
pl
dc.identifier.doi
10.1186/s12933-019-0850-0
pl
dc.identifier.eissn
1475-2840
dc.title.journal
Cardiovascular Diabetology
pl
dc.language.container
eng
pl
dc.affiliation
Wydział Lekarski : Instytut Kardiologii
pl
dc.affiliation
Wydział Lekarski : Klinika Chorób Metabolicznych
pl
dc.subtype
Article
pl
dc.identifier.articleid
49
pl
dc.rights.original
CC-BY; otwarte czasopismo; ostateczna wersja wydawcy; w momencie opublikowania; 0